This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Philip Morris (PM) Misses Q2 Earnings and Sales; Stock Down
by Zacks Equity Research
Philip Morris (PM) lagged the Zacks Consensus Estimate on both earnings and revenues in the second quarter 2017. The company also lowered its earnings guidance for 2017.
Consumer Staples Stock Earnings on Jul 20: PM and SCHL
by Zacks Equity Research
These consumer staples stocks are unlikely to beat earnings estimates in Q2 despite the sector's affluence on the back on rising consumer confidence.
Top Ranked Income Stocks to Buy for July 17th
by Zacks Equity Research
Here are four stocks with buy rank and strong income characteristics for investors to consider today, July 17th:
Reynolds American (RAI) Stock Lacks Luster: What Lies Ahead?
by Zacks Equity Research
Reynolds American (RAI) is going through a tough time as evident from its dismal earnings and sales surprise history.
Philip Morris (PM) Up 4.3% Since Earnings Report: Can It Continue?
by Zacks Equity Research
Philip Morris (PM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Can Consumer Staples Overcome Headwinds?
by Zacks Equity Research
Despite rising consumer spending and moderate improvement in U.S. economic growth, the consumer staples sector doesn't seem to be the perfect choice for investors right now.
Earnings Season Scorecard & Today's Top Stock Research Reports
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including General Electric (GE), Bank of America (BAC), UnitedHealth (UNH) and Philip Morris (PM).
Philip Morris (PM) Misses Q1 Earnings and Sales; Stock Down
by Zacks Equity Research
Philip Morris (PM) came out with first-quarter 2017 results, wherein adjusted earnings of 98 cents a share missed the Zacks Consensus Estimate of $1.03.
Should You Sell Philip Morris (PM) Before Earnings?
by Zacks Equity Research
Philip Morris (PM) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Why Philip Morris (PM) Stock Seems a Good Pick Right Now
by Zacks Equity Research
Despite the health related concerns associated with tobacco, one of the dominant players in this space, Philip Morris International Inc.'s (PM) has managed to entice investors on the back of strategic initiatives.
Top Research Reports for Alphabet, 3M and P&G
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Alphabet (GOOGL), 3M (MMM), and Procter & Gamble (PG).
Philip Morris' IQOS Less Harmful as per Recent Research
by Zacks Equity Research
Philip Morris International Inc. (PM) has announced that its reduced-risk product ??? IQOS has been declared as safer than conventional cigarettes by a latest research conducted by Osaki Hospital Tokyo Heart Center.
Philip Morris (PM) Invests in Reduced Risk Tobacco Category
by Zacks Equity Research
In an attempt to combat declining volumes, Philip Morris International Inc. (PM) continues to boost presence in the unconventional tobacco category.
Analyst Reports for McDonald's, Cisco, Philips Morris and General Dynamics
by Sheraz Mian
Today's Research Daily features new research reports on 17 major stocks, including Cisco (CSCO), Philip Morris (PM), McDonald's (MCD) and General Dynamics (GD).
What's Behind the Rally in Tobacco Stocks?
by Zacks Equity Research
Despite the tobacco products carrying a stigma of health issues, the shares of tobacco titans portray a different picture with most reaching highs never seen before.
Will Reynolds-British American Merger be a Reality Soon?
by Zacks Equity Research
The highly anticipated tobacco merger between Reynolds American Inc. (RAI) and British American Tobacco (BTI) seem to have cleared the antitrust hurdles from the U.S authorities.
Why Is Philip Morris (PM) Up 11.5% Since the Last Earnings Report?
by Zacks Equity Research
Philip Morris (PM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Tobacco Stocks Queued Up for Q4 Earnings Release: RAI, TPB
by Zacks Equity Research
The fourth-quarter earnings season is in full swing with almost 55% of the total S&P 500 members already having reported their quarterly results.
Philip Morris (PM) Q4 Earnings Miss, Sales Beat
by Zacks Equity Research
Philip Morris International Inc. (PM) is one of the leading manufacturer and distributor of cigarettes and smokeless tobacco products in approximately 180 countries.
Reynolds Agrees to Merge with British American Tobacco
by Zacks Equity Research
Tobacco giant, Reynolds American Inc. (RAI) has finally agreed to the merger proposal of British American Tobacco (BTI), under which the latter will take over the remaining 57.8% of Reynolds for $49 billion.
Research Reports on Exxon, P&G and the Q4 Earnings Season
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including ExxonMobil (XOM), Procter & Gamble (PG), and Philip Morris (PM).
Why You Should Avoid Philip Morris (PM) Stock This Year?
by Zacks Equity Research
The tobacco industry is currently going through difficult times and Philip Morris International Inc. (PM) is no exception to the trend.
New Research Reports for Pepsi, Philips Morris & Dow Chemical
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Pepsi (PEP), Philip Morris (PM) and Dow Chemical (DOW).
Top Research Reports for Goldman Sachs, Comcast & Abbott Labs
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Abbott (ABT), Comcast (CMCSA) and Goldman Sachs (GS).
Top 7 Research Reports for July 20, 2016
by Sheraz Mian
Today's must-read reports are for UnitedHealth (UNH), Philip Morris (PM) and Thermo Fisher (TMO).